Experimental, genetic, translational, and epidemiological data demonstrated that cytokines including IL-1 and IL-6 were related to several cardiovascular diseases.2,4–7 A recent randomized trial on inflammation-modifying drugs targeting this pathway has proven their efficacy for some cardiovascular diseases, indicating DMARD as a potential drug for cardiovascular disease. Here, IL6 is linked to cardiovascular disorder.